Todd Harris's Net Worth
$36.2 Million
Who is Todd Harris?
Todd Harris has an estimated net worth of $36.2 Million. This is based on reported shares across multiple companies, which include Tyra Biosciences, Inc., and Sienna Biopharmaceuticals, Inc..
SEC CIK
Todd Harris's CIK is 0001711463
Past Insider Trading and Trends
2023 was Todd Harris's most active year for acquiring shares with 15 total transactions. Todd Harris's most active month to acquire stocks was the month of February. 2023 was Todd Harris's most active year for disposing of shares, totalling 35 transactions. Todd Harris's most active month to dispose stocks was the month of February. 2023 saw Todd Harris paying a total of $138,637.34 for 385,404 shares, this is the most they've acquired in one year. In 2024 Todd Harris cashed out on 100,000 shares for a total of $1,656,085.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Tyra Biosciences, Inc. (TYRA) Snapshot price: $20.59
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.42% | -62.72K |
$27.28 | -$1,711,247.20 | 1.36M |
Oct 18 - Oct 21
| |||
Form 4
| -3.98% | -58.73K |
$25.77 | -$1,513,271.34 | 1.42M |
Oct 15 - Oct 17
| |||
Form 4
| +0.09% | 1.35K |
$6.58 | $8,881.65 | 1.51M |
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
| +0.13% | 1.88K |
$6.58 | $12,368.52 | 1.5M |
Mar 15
| |||
Form 4
| -6.24% | -100.00K |
$16.56 | -$1,656,085.10 | 1.5M |
Feb 2 - Feb 5
| |||
Form 4
| +0.09% | 1.42K |
$6.58 | $9,348.76 | 1.6M |
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
| -1.49% | -24.19K |
$17.01 | -$411,512.22 | 1.6M |
Jun 22 - Jun 23
| |||
Form 4
| -4.46% | -75.81K |
$17.12 | -$1,297,542.10 | 1.63M |
Jun 16 - Jun 21
| |||
Form 4
|
—
|
0
|
$9.16 | -$286,291.61 | 1.7M |
Jun 13 - Jun 15
| |||
Form 4
|
—
|
0
|
$9.19 | -$27,752.00 | 1.7M |
Apr 3
| |||
Form 4
|
—
|
0
|
$9.16 | -$59,819.78 | 1.7M |
Mar 29 - Mar 31
| |||
Form 4
|
—
|
0
|
$9.13 | -$81,290.00 | 1.7M |
Mar 24 - Mar 28
| |||
Form 4
|
—
|
0
|
$9.13 | -$264,495.00 | 1.7M |
Mar 21 - Mar 23
| |||
Form 4
| +0.11% | 1.81K |
$6.58 | $11,894.83 | 1.7M |
Mar 15
| |||
Form 4
| +0.18% | 3.13K |
$8.53 | $26,642.19 | 1.7M |
Mar 15 - Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| +2.05% | 34.01K |
—
|
—
| 1.7M |
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sienna Biopharmaceuticals, Inc. No price found
Head Corporate Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
| -0.02% | -100.00 |
$20.00 | -$2,000.00 | 570.99K |
Scheduled
|
Apr 30
| ||
Form 4
| -0.17% | -975.00 |
$20.00 | -$19,500.00 | 571.09K |
Scheduled
|
Apr 23 - Apr 25
| ||
Form 4
| -3.05% | -18.01K |
$20.08 | -$361,619.18 | 572.07K |
Scheduled
|
Apr 17 - Apr 18
| ||
Form 4
| -0.64% | -3.78K |
$20.02 | -$75,640.84 | 590.08K |
Scheduled
|
Apr 10
| ||
Form 4
| -1.36% | -8.21K |
$20.00 | -$164,205.39 | 593.86K |
Scheduled
|
Apr 5 - Apr 9
| ||
Form 4
| -0.97% | -5.88K |
$20.00 | -$117,520.00 | 602.07K |
Scheduled
|
Mar 19
| ||
Form 4
| -0.56% | -3.45K |
$20.11 | -$69,429.04 | 607.94K |
Scheduled
|
Mar 12
| ||
Form 4
| -3.27% | -20.67K |
$20.03 | -$413,961.06 | 611.39K |
Scheduled
|
Mar 7 - Mar 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||